The Hippo pathway is a kinase cascade stimulated by the YAP1 oncogene, the activation of which is associated with resistance to EGFR inhibitors in EGFR-mutated lung adenocarcinoma [59,60,61]. The gene discussed is EGFR; the disease is lung adenocarcinoma.